International Journal of Nutrition and Food Sciences

| Peer-Reviewed |

Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies

Received: 19 October 2016    Accepted: 22 November 2016    Published: 26 December 2016
Views:       Downloads:

Share This Article

Abstract

Because of its content of saturated fatty acids, palm oil is often considered as being atherogenic nutritionally, and would therefore purveyor of certain diseases including cardiovascular disease. The present study was conducted to assess changes in the lipid profile and lipoprotein of patients with ischemic heart, consumers versus non-consumers of palm oil. The study involved 120 patients enrolled at the Cardiology Institute of Abidjan, divided into 3 groups. Group 1 consisted of 50 patients consumers of refined palm oil, group 2, of 40 patients taking the two forms of oil (refined and raw red), and group 3 comprised 30 patients not consuming palm oil (control group). The lipid parameters and lipoprotein measured were total cholesterol, triglycerides, HDL and LDL cholesterol, and the atherogenic index. In patient’s consumers of refined palm oil, after 04 weeks of diet, 58% had normal cholesterol rate, 14% hypercholesterolemia and 28% with low cholesterol rate. As for patients taking both types of palm oil, 57.50% had normal cholesterol rate, 15% hypercholesterolemia and 27.50% with low cholesterol rate. Patients, non-consumers of palm oil had low cholesterol rate at 26.67%. The difference was not significant. Whatever the form of consumption, we notice a variation in the cholesterol rate as well as a tendency of low cholesterol rate after four weeks of dieting, with no significant difference. The same pattern was observed with the dosages of triglycerides, LDL cholesterol, HDL cholesterol and atherogenic index, for which changes were also not significant in the 03 groups. The consumption or not of palm oil, whatever the form and the duration of consumption, had no significant influence on serum lipid and lipoprotein parameters and the atherogenic index of patients carriers of ischemic heart disease. This study, although preliminary, has allowed determining that palm oil is harmless in patients with ischemic heart disease, consumers or non consumers of that oil.

DOI 10.11648/j.ijnfs.20170601.12
Published in International Journal of Nutrition and Food Sciences (Volume 6, Issue 1, January 2017)
Page(s) 6-11
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Palm Oil, Ischemic Heart Disease, Lipid Profile, Lipoprotein, Atherogenic Index

References
[1] Organisation Mondiale de la Santé. Principales causes de mortalité dans le monde; les maladies cardio-vasculaires sont-elles la principale cause de décès partout dans le monde? [Internet]. Genève: OMS [consulté le 21/03/2016]. Disponible sur : www.who.int/mediacentre/factsheets/fs310/fr/index2.html
[2] DO Abegunde, T Adam. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 2007, pp. 1929-38.
[3] TA Gaziano. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff 26 (1), 2007, pp. 13-24.
[4] M Diao, M Sarr, A Kane, A Kane, F Damorou, D Balde, Working Group on Tropical Cardiology, Société Française de Cardiologie. Optimizing the management of acute coronary syndromes in sub-Saharan Africa: A statement from the AFRICARDIO 2015 Consensus Team. Arch Cardiovasc Dis, 109 (6-7), 2016, pp. 376-83.
[5] SV Shah, AM Shukla, C Bose, AG Basnakian, M Rajapurkar. Recent advances in understanding the pathogenesis of atherosclerosis in CKD patients. J Ren Nutr, vol 25 (2), 2015, pp. 205-8.
[6] J-L Bordeau. Oxidative stress in the atherosclerotic process. Paris: Elsevier; 2006. P144-50.
[7] A Mancini, E Imperlini, E Nigro, C Montagnese, A Daniele, S Orrù, P Buono. Biological and nutritional properties of palm oil and palmitic acid: Effects on health. Molecules 20 (9), 2015, pp. 17339-61.
[8] L’huile de palme est-elle mauvaise pour la santé? la santé par les aliments > Risque santé, www.topsanté.com consulté le 05/03/2016.
[9] MP Lehucher-Michel, JF Lesgards, O Delubac. stress oxydant et pathologies humaines, bilan et perspectives préventives. Presse Med, 30 (21), 2001, pp. 1076-81.
[10] M Satge, P J Toury. Alimentation et pathologie nutritionnelle en Afrique noire. Paris: Maloine; 1974. p204-08.
[11] A BEKE. Evaluation des connaissances sur les valeurs nutritionnelles de l’huile de palme chez les patients ayant l’hypertension artérielle à l’institut de cardiologie d’Abidjan. Thèse Méd. Abidjan, N°5935/2015, 119P.
[12] S YAPO. Evaluation de la connaissance nutritionnelle sur l’huile de palme chez les patients porteurs de cardiopathies à l’institut de cardiologie d’Abidjan. Thèse Méd. Abidjan, N° 5931/2015, 123p.
[13] N Wattanapenpaiboon, MW Wahlqvist. Phytonutrient deficiency: the place of palm fruit. Asia Pac J Clin Nutr, 12 (3), 2003, pp. 363-368.
[14] D Pacetti, R Gagliardi, M Balzano, NG Frega, ML Ojeda, M Borrero, A Ruiz, P Lucci. Changes in the fatty acid profile and phospholipid molecular species composition of human erythrocyte membranes after hybrid palm and extra virgin olive oil supplementation. J Agric Food Chem, 64 (27), 2016, pp. 5499-507.
[15] JC Jacquemard. Le palmier à huile. Coll. Agricultures tropicales de poche. Ed : Quae/CTA/Presses agronomiques de Gembloux, 2012, 240p.
[16] PE Ebong, DU Owu, EU Isong. Influence of palm oil (Elaeis guineensis) on health. Plant Foods Hum Nutr, 53 (3), 1999, pp. 209-22.
[17] SF Morigbé. Bilan athérolipidique du sujet ivoirien sain nourri à l’huile de palme en contexte fermé non domestique. Thèse Méd Abidjan, N°2796/2001, 128p.
[18] AA Monde. Caractérisations des différentes formes variétales de l’huile de palme de Côte d’Ivoire : Propriétés anti oxydantes. Thèse pour le doctorat de l’Université de Montpellier 2, Ecole Doctorale : Sciences des aliments (SPSA), option Nutrition Santé, Septembre 2011, Université Montpellier 2, Sciences et Techniques du Languedoc, France, 257p.
[19] A Mondé, M-A Carbonneau, F Michel et al. Potential health implication of in vitro human LDL-Vitamin E oxidation modulation by polyphenols deriving from Côte d’Ivoire’s oil palm species. J. Agric. Food Chem, 59, 2011, pp. 9166–9171.
[20] Comité Malaisien sur l’huile de palme. Livre de poche sur les utilisations de l’huile de palme. 6e Ed, 2009, 178p.
[21] Les apports nutritionnels de référence. ANREF. Institute of Medicine (IOM), National Academies Press, Washington D. C, 2006, 560p.
[22] ANSES. Agence nationale de sécurité sanitaire de l’alimentation (anciennement AFSSA). https://www.anses.fr/. Consulté le 13/07/2016.
[23] AE Yapo, M Assayi, NB Aka. Les valeurs de référence de 21 constituants biochimiques sanguins de l’Ivoirien adulte présumé sain. Pub Med Afr, 110, 1990, pp. 49-57.
[24] E Bertrand, WF Muna, SM Diouf, A Ekra, A Kane, S Kingue, P Kombila, M Mbaissoroum, A Niakara, A Ould Eba, AO Sidi Al, Y Yapobi. Cardiovascular emergencies in Subsaharan Africa. Arch Mal Coeur Vaiss, 99 (12), 2006, pp. 1159-65.
[25] A Froment, M Gouton. Hypertension artérielle. In Delahaye JP cardiologie 2e Ed Paris, Masson 2000, pp. 309-329.
[26] Fonds français pour l’alimentation et la santé : Etats des lieux novembre 2012. L’huile de palme : Aspects nutritionnels, sociaux et environnementaux 20p. Disponible sur http://alimentation-sante.org/wp-content/uploads/2012/12/Etatdeslieux_HdP_1112.pdf [Consulté le 11/10/15].
[27] F Coulibaly. Evaluation de la connaissance sur les valeurs nutritionnelles de l’huile de palme chez les patients diabétiques reçus au service d’endocrinologie-diabétologie du CHU de Yopougon et au CADA. [Thèse Med]. Abidjan, UFR Sciences Médicales Université FHB, N°5935/2015, 119p.
[28] ES Lega. Evaluation de la connaissance sur les valeurs nutritionnelles de l’huile de palme chez les patients en surpoids et obèses au service de nutrition de l’Institut National de Santé Publique d’Adjamé. [Thèse Méd]. Abidjan, UFR Sciences Médicales Université FHB, N°5989/2015, 126p.
[29] EU Onyeali, AC Onwuchekwa, CC Monago et al. Plasma profil lipidique des rats albinos Wistar nourris huile de palme régimes supplémentés. Int J Biol Chem Sci, 10, 2010, pp. 1-7.
[30] AM Ladeia, E Costa-Matos, R Barata-Passos, A Costa Guimarães. A palm oil-rich diet may reduce serum lipids in healthy young individuals. Nutrition, 24 (1), 2008, pp. 11-5.
[31] J Zhang, CR Wang, AN Xue, KY Ge. Effects of red palm oil on serum lipids and plasma carotenoids level in Chinese male adults. Biomed Sci Environ, 16, 2003, pp. 348-354.
[32] S Basu, KS Babiarz, S Brahmi, S Vellakkal, D Stuckler, JD Goldhaber-Fiebert. Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model. BMJ, 347, 2013, pp, 1-9.
[33] J Aranceta, C Perez-Rodrigo. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Br J Nutr, 107 (Suppl 2), 2012, pp. S8–22.
[34] J Zhang, W Ping, W Chunrong, CX Shou, G Keyou. Non hypercholesterolemic effects of a palm oil diet in Chinese adults. J Nutr, 127 (Suppl), 1997, pp. 509S–13S.
[35] E Dauqan, HA Sani, A Abdullah, ZM Kasim. Effect of different vegetable oils (red palm olein, palm olein, corn oil and coconut oil) on lipid profile in rat. Food Nutr Sc, 2, 2011, pp. 253-258.
[36] C-M Boon, M-H Ng, Y-M Choo, S-L Mok. Super, red palm and palm oleins improve the blood pressure, heart size, aortic media thickness and lipid profile in spontaneously hypertensive rats. PLOS ONE | www.plosone.org 8 (2/ e55908), 2013, pp 1-12.
[37] J Sakande, JL Coulibaly, N Njikeutchi et al. Etablissement des valeurs de références de 15 constituants biochimiques sanguins chez l’adulte burkinabé à Ouagadougou [En ligne] In : Annales de biochimie Disponible sur www.jle.com Page consultée le 03/07/16.
[38] EJ Schaefer, P Anthanont, BF Asztalos. High-density lipoprotein metabolism, composition, function, and deficiency. Curr Opin Lipidol, vol 25 (3), 2014, pp. 194-9.
[39] J-M Lecerf. L’huile de palme : aspects nutritionnels et métaboliques. Rôle sur le risque cardiovasculaire. Oléagineux Corps Gras Lipides, 10, 2013, pp 76-84.
[40] KC Sulli, J Sun, DW Girrard et al. Effets de la β-carotène et du tocophérol sur les niveaux de cholestérol dans les tissus et les triglycérides chez les lapins hypercholesteroleamic. J Nutr Bio Chem, 9, 1998, pp. 344-350.
Author Information
  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Service of Medicine, Institute of Cardiology, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Medical Biochemistry Laboratory, School of Medical Sciences, University Felix HOUPHOUET-BOIGNY, Abidjan, C?te d’Ivoire

  • Biochemistry Laboratory of the Institute of Cardiology, Abidjan, C?te d’Ivoire

Cite This Article
  • APA Style

    Monde Aké Absalome, Camara-Cisse Massara, Konan Gervais, Coulibaly Iklo, Adeoti Mansour, et al. (2016). Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies. International Journal of Nutrition and Food Sciences, 6(1), 6-11. https://doi.org/10.11648/j.ijnfs.20170601.12

    Copy | Download

    ACS Style

    Monde Aké Absalome; Camara-Cisse Massara; Konan Gervais; Coulibaly Iklo; Adeoti Mansour, et al. Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies. Int. J. Nutr. Food Sci. 2016, 6(1), 6-11. doi: 10.11648/j.ijnfs.20170601.12

    Copy | Download

    AMA Style

    Monde Aké Absalome, Camara-Cisse Massara, Konan Gervais, Coulibaly Iklo, Adeoti Mansour, et al. Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies. Int J Nutr Food Sci. 2016;6(1):6-11. doi: 10.11648/j.ijnfs.20170601.12

    Copy | Download

  • @article{10.11648/j.ijnfs.20170601.12,
      author = {Monde Aké Absalome and Camara-Cisse Massara and Konan Gervais and Coulibaly Iklo and Adeoti Mansour and Gauze-Gnagne-Agnero Chantal and Djohan Ferdinand and Emien Kouatchi Sylvain and Niamke Germaine and Hauhouot-Attoungbre Marie-Laure},
      title = {Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies},
      journal = {International Journal of Nutrition and Food Sciences},
      volume = {6},
      number = {1},
      pages = {6-11},
      doi = {10.11648/j.ijnfs.20170601.12},
      url = {https://doi.org/10.11648/j.ijnfs.20170601.12},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.ijnfs.20170601.12},
      abstract = {Because of its content of saturated fatty acids, palm oil is often considered as being atherogenic nutritionally, and would therefore purveyor of certain diseases including cardiovascular disease. The present study was conducted to assess changes in the lipid profile and lipoprotein of patients with ischemic heart, consumers versus non-consumers of palm oil. The study involved 120 patients enrolled at the Cardiology Institute of Abidjan, divided into 3 groups. Group 1 consisted of 50 patients consumers of refined palm oil, group 2, of 40 patients taking the two forms of oil (refined and raw red), and group 3 comprised 30 patients not consuming palm oil (control group). The lipid parameters and lipoprotein measured were total cholesterol, triglycerides, HDL and LDL cholesterol, and the atherogenic index. In patient’s consumers of refined palm oil, after 04 weeks of diet, 58% had normal cholesterol rate, 14% hypercholesterolemia and 28% with low cholesterol rate. As for patients taking both types of palm oil, 57.50% had normal cholesterol rate, 15% hypercholesterolemia and 27.50% with low cholesterol rate. Patients, non-consumers of palm oil had low cholesterol rate at 26.67%. The difference was not significant. Whatever the form of consumption, we notice a variation in the cholesterol rate as well as a tendency of low cholesterol rate after four weeks of dieting, with no significant difference. The same pattern was observed with the dosages of triglycerides, LDL cholesterol, HDL cholesterol and atherogenic index, for which changes were also not significant in the 03 groups. The consumption or not of palm oil, whatever the form and the duration of consumption, had no significant influence on serum lipid and lipoprotein parameters and the atherogenic index of patients carriers of ischemic heart disease. This study, although preliminary, has allowed determining that palm oil is harmless in patients with ischemic heart disease, consumers or non consumers of that oil.},
     year = {2016}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effects of Palm Oil Consumption on Lipidic and Lipidoproteinic Profiles in Patients Suffering from Ischemic Heart Pathologies
    AU  - Monde Aké Absalome
    AU  - Camara-Cisse Massara
    AU  - Konan Gervais
    AU  - Coulibaly Iklo
    AU  - Adeoti Mansour
    AU  - Gauze-Gnagne-Agnero Chantal
    AU  - Djohan Ferdinand
    AU  - Emien Kouatchi Sylvain
    AU  - Niamke Germaine
    AU  - Hauhouot-Attoungbre Marie-Laure
    Y1  - 2016/12/26
    PY  - 2016
    N1  - https://doi.org/10.11648/j.ijnfs.20170601.12
    DO  - 10.11648/j.ijnfs.20170601.12
    T2  - International Journal of Nutrition and Food Sciences
    JF  - International Journal of Nutrition and Food Sciences
    JO  - International Journal of Nutrition and Food Sciences
    SP  - 6
    EP  - 11
    PB  - Science Publishing Group
    SN  - 2327-2716
    UR  - https://doi.org/10.11648/j.ijnfs.20170601.12
    AB  - Because of its content of saturated fatty acids, palm oil is often considered as being atherogenic nutritionally, and would therefore purveyor of certain diseases including cardiovascular disease. The present study was conducted to assess changes in the lipid profile and lipoprotein of patients with ischemic heart, consumers versus non-consumers of palm oil. The study involved 120 patients enrolled at the Cardiology Institute of Abidjan, divided into 3 groups. Group 1 consisted of 50 patients consumers of refined palm oil, group 2, of 40 patients taking the two forms of oil (refined and raw red), and group 3 comprised 30 patients not consuming palm oil (control group). The lipid parameters and lipoprotein measured were total cholesterol, triglycerides, HDL and LDL cholesterol, and the atherogenic index. In patient’s consumers of refined palm oil, after 04 weeks of diet, 58% had normal cholesterol rate, 14% hypercholesterolemia and 28% with low cholesterol rate. As for patients taking both types of palm oil, 57.50% had normal cholesterol rate, 15% hypercholesterolemia and 27.50% with low cholesterol rate. Patients, non-consumers of palm oil had low cholesterol rate at 26.67%. The difference was not significant. Whatever the form of consumption, we notice a variation in the cholesterol rate as well as a tendency of low cholesterol rate after four weeks of dieting, with no significant difference. The same pattern was observed with the dosages of triglycerides, LDL cholesterol, HDL cholesterol and atherogenic index, for which changes were also not significant in the 03 groups. The consumption or not of palm oil, whatever the form and the duration of consumption, had no significant influence on serum lipid and lipoprotein parameters and the atherogenic index of patients carriers of ischemic heart disease. This study, although preliminary, has allowed determining that palm oil is harmless in patients with ischemic heart disease, consumers or non consumers of that oil.
    VL  - 6
    IS  - 1
    ER  - 

    Copy | Download

  • Sections